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A B S T R A C T
Purpose: Surgery is regarded as a common treatment option for patients with mesial temporal lobe
epilepsy (MTLE) as a result of hippocampal sclerosis (HS). However, approximately one-third of patients
with intractable epilepsy did not become seizure-free after tailored resection strategies. It would be
compelling to identify predictive factors of postoperative seizure outcomes. Our aim was to assess the
correlation between HS classiﬁcation and long-term postoperative seizure outcome in patients with
MTLE due to HS.
Methods: To investigate HS classiﬁcation, semi-quantitative analysis and immunohistochemical
staining of neuronal nuclei (NeuN) were performed on 100 postoperative hippocampal specimens.
All patients had a 1–7 year postoperative follow-up. The postoperative seizure outcome was evaluated
using International League Against Epilepsy (ILAE) outcome classiﬁcation.
Results: Three types of HS were recognized. The highest incidence of initial precipitating injury (IPI) was
noted in the HS ILAE type 1 group (53.1%). The most favorable long-term seizure outcome was also noted
in the HS ILAE type 1 group. The shortest epilepsy duration was recorded in the HS ILAE type 2 group
(mean epilepsy duration = 6.64  5.83 years). The completely seizure free rate of patients in all groups
declined with an increase in time.
Conclusions: Our study for the ﬁrst time demonstrated a signiﬁcant correlation between HS ILAE types
and long-term postoperative seizure outcome in patients with MTLE due to HS. Therefore, HS ILAE types
have predictive value in long-term seizure outcome following epilepsy surgery.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Patients with epilepsy respond differently to medications.
Approximately 20–30% of patients with epilepsy have drug-
resistant epilepsy, and epilepsy surgery is the treatment of choice
for the refractory epilepsy. However, after a follow-up of 5 years,
the number of patients remaining seizure-free begins to decline,1–4
consistent with our recent results.4 In addition, not all patients* Corresponding author at: Department of Neurosurgery, The First Afﬁliated
Hospital of Harbin Medical University, Youzheng Street 23, Nangang District,
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1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights rewith similar seizure types and epileptogenic focus localizations
become seizure-free after surgery. This indicates that the
mechanisms underlying poor postoperative outcomes are unclear.
Therefore, it would be compelling to identify predictive factors of
postoperative seizure outcomes.
The hippocampus is a highly sophisticated structure, including
CA1–CA4 subﬁelds, dentate gyrus (DG), ﬁmbria, subiculum (SUB),
parasubiculum, and entorhinal cortex (ERC).5 Hippocampal
sclerosis (HS) is a pathological hallmark of mesial temporal lobe
epilepsy (MTLE). MTLE due to HS are more frequently drug
resistant. Tailored resection strategies, including selective amyg-
dalohippocampectomies and standard temporal lobectomies, are
established treatment modalities. The postoperative seizure
freedom rate in patients with MTLE due to HS is approximately
56–91%.1,3,6,7 Neuropathological investigations indicate that HS isserved.
Table 1
Demographic and clinical characteristics of 100 patients.
Demographic and clinical characteristics Data
Mean age at surgery (means  SD, (min–max) years) 27.72  10.67 (2–61)
Gender (female/male) (N (%)) 35 (35%)/65 (65%)
Epilepsy duration (means  SD, (min–max) years) 13.31  10.18 (0.42–43)
With IPI (N (%)) 31 (31%)
EEG (abnormal N (%)) 100 (100%)
24 h-VEEG (abnormal N (%)) 100 (100%)
Hippocampal MRI (abnormal N (%)) 82 (82%)
Head FDG-PET/CT (abnormal N (%)) 23 (23%)
Intro-operation ECoG (abnormal N (%)) 100 (100%)
Intro-operation deep electrodes (abnormal N (%)) 100 (100%)
Side of operation (left/right) (N (%)) 59 (59%)/41 (41%)
Bilateral abnormalities (N (%)) 2 (2%)
SD: standard deviation, N: number of patients, IPI: initial precipitating injury, EEG:
electroencephalogram, VEEG: video-EEG, FDG-PET/CT: ﬂuoro-deoxy glucose
positron emission tomography combined with computed tomography, and ECoG:
cortical electroencephalogram.
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hippocampal subﬁelds (CA1–CA4, DG). Thus, HS can be separated
into distinct pathological subgroups according to its subtle
differences.8,9 International League Against Epilepsy (ILAE) has
reported a new classiﬁcation of HS.10 Different types of HS may be
associated with different clinical phenotypes and postoperative
outcomes.11,12 However, the association of long-term postopera-
tive seizure outcomes with different HS types has never been
reported. Our aim was to assess the correlation between HS ILAE
types and postoperative seizure outcome in a cohort of 100 patients
with MTLE due to HS.
2. Methods
2.1. Study population
This study was approved by the Institutional Review Board of
the First Afﬁliated Hospital of Harbin Medical University, and the
participants gave informed consent. For the minors/children
enrolled in our study, we obtained the written informed consent
from the next of kin, caretakers, or guardians on behalf of them. A
total of 100 patients were included in the Department of
Neurosurgery at the First Afﬁliated Hospital of Harbin Medical
University between 2006 and 2013. All cases were considered to
have refractory epilepsy, after at least two ﬁrst-line anti-epileptic
drugs failed. The preoperative evaluation included cognitive and
neuropsychological testing, electroencephalogram (EEG), video-
electroencephalographic monitoring, high-resolution hippocam-
pal 1.5 T or 3 T magnetic resonance imaging (MRI), and ﬂuoro-
deoxy glucose positron emission tomography combined with
computed tomography (FDG-PET/CT). The mesio-temporal foci
were diagnosed with EEG and 24 h video-electroencephalograph-
ic monitoring. Abnormal hippocampal MRI signals, including
hippocampal atrophy and temporal horn dilatation on coronal T1-
weighted images and increased signal intensity within the
hippocampus on T2-weighted images and ﬂuid attenuated
inversion recovery (FLAIR) images, could be shown in some
patients. However, the other patients indistinctively showed
abnormal signals on their hippocampal MRI. Indeed, it is difﬁcult
to distinguish the slight atrophy of a single hippocampal subﬁeld
on MRI by naked eyes. According to the abnormal spike wave and
sharp wave in mesio-temporal lobe on EEG and 24 h-video EEG
(VEEG), we performed FDG-PET/CT in patients who had indistinc-
tive abnormal signals on their hippocampal MRI. The low
metabolism of mesio-temporal lobe could be detected. The senior
author, who has had nearly 15 years of experience in the surgical
treatment of intractable epilepsy, was responsible for identifying
these ﬁndings and the criteria used for diagnosing HS. All patients
underwent selective amygdalohippocampectomies or standard
anterior temporal lobectomies with amygdalohippocampec-
tomies by the senior author. During operation, cortical electro-
encephalogram (ECoG) and deep electrodes were used to further
identify the abnormal electrical activity. The hippocampal speci-
mens of these patients were collected for pathological and
histological research. Postoperative data were obtained from
patients’ interviews during the postoperative outpatient visits or
by telephone interviews at least once per year. The postoperative
seizure outcome was evaluated using ILAE outcome classiﬁca-
tion13 after 7-year follow-up. The clinical characteristics of
patients were categorized (Table 1). The patients were divided
into three groups according to their histological results. Seven
hippocampal specimens served as controls. Three hippocampal
control specimens were obtained from neurologically healthy
autopsies and the written consents were given by the next of kin.
The other control specimens were obtained from patients who
were diagnosed with intracranial space-occupying lesions(tumors or cerebral cavernous malformations) next to the
hippocampus and who had only one or two seizures. Hippocam-
pectomies were performed in these patients to avoid postopera-
tive secondary epilepsy. All the procedures were standardized in
the framework of the study. The ﬁrst author participated in all the
procedures, and veriﬁed by the corresponding author.
2.2. Tissue preparation
Hippocampal specimens were dissected into 3-mm-thick slices
along the long axis. All tissues were ﬁxed with 10% formalin
overnight, and then cut at 4 mm with a microtome (Leica). The
sections were mounted onto charged slides, air-dried in an oven at
70 8C for 2 h, cleared in xylene, and deparafﬁnized in descending
alcohol concentrations. The hippocampal pyramidal neurons and
granule cells of the DG were immunostained for the neuronal core
antigen NeuN. The staining was performed with the streptavidin-
peroxidase method, and 3,30-diaminobenzidine was added as a
chromogen. Hematoxylin counterstaining was ﬁnally conducted.
2.3. The quantitative measurement method
The quantitative measurement of neuronal cell numbers was
employed as previously described.9 Neuronal cell bodies immu-
nohistochemically stained (NeuN) could be clearly tagged on the
computer screen. The neurons were manually counted separately
within different hippocampal subﬁelds with a microcomputer
imaging system (Leica Application Suite, Version 4.3.0) coupled to
a microscope (Leica DM 4000B). The number of neurons was
calculated in 4 visual ﬁelds in CA4 region and in 10 visual ﬁelds in
CA1 region at 200 objective magniﬁcation, representing
1.21 mm2. The mean number of neurons/mm2 was calculated,
and the values were transformed into z-scores [z = (score  mean
of the population)/standard deviation of the population]. The
pathological features of neurons loss within CA1 and CA4 regions
were categorized (Fig. 1 and Table 2).
2.4. The clinicopathological classiﬁcation system for HS
The ILAE classiﬁcation system was employed to identify the HS
types in our study.10 According to the semi-quantitative methods,
3 types of HS were classiﬁed. HS ILAE type 1 refers always to severe
neuronal cell loss and gliosis predominantly in CA1 and CA4
regions, HS ILAE type 2 shows predominant neuronal cell loss and
gliosis in CA1 region, HS ILAE type 3 demonstrates predominant
neuronal cell loss and gliosis in CA4 region.
Fig. 1. Histopathological ﬁndings in patients with MTLE. (A) Coronal section of normal hippocampus; (B) HS ILAE type 1: signiﬁcant neuron loss in CA1 and CA4 regions (red
asterisk); (C) HS ILAE type 2: signiﬁcant neuron loss in CA1 region (red asterisk); (D) HS ILAE type 3: signiﬁcant neuron loss in CA4 region (red asterisk); (E) Histogram
representing comparison of neuronal density in different hippocampal subﬁelds among the different groups (*P < 0.01). (For interpretation of the references to color in this
ﬁgure caption, the reader is referred to the web version of this article.)
Table 2
Neuronal density in CA1 and CA4 regions in the different groups.
N Neuronal density (CA1) Neuronal density (CA4)
Mean SD (neurons/mm2) Mean SD (neurons/mm2)
Normal control 7 30.3 0.96 29.4 0.77
HS ILAE type 1 49 17.2 0.66 15.7 0.99
HS ILAE type 2 27 17.0 1.59 28.6 0.64
HS ILAE type 3 24 29.9 0.66 16.1 0.98
N: number of patients, SD: standard deviation, HS: hippocampal sclerosis, and ILAE: International League Against Epilepsy.
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SPSS software (Windows, Version 19.0, IBM Corporation,
Armonk, NY, USA) was used for the statistical analysis. Kaplan–
Meier curves were used to specify different lengths of follow-up.
One variable was measured: the time to the ﬁrst postoperative
seizure. Continuous variables were compared via one-way analysis
of variance (ANOVA). Categorical variables were examined by the
chi-square test and Fisher’s exact test as appropriate. A P value of
less than 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Patient characteristics
A total of 100 patients with MTLE were included in our cohort
study. Demographic and clinical characteristics of those patients
were categorized (Table 1). Those characteristics included mean
age at surgery, gender, duration between epilepsy and surgery, any
initial precipitating injury (IPI), EEG, 24 h-VEEG, hippocampal MRI,
head FDG-PET/CT, intro-operation ECoG, intro-operation deep
electrodes, side of operation, and bilateral abnormalities.3.2. The characterization of HS in postoperative specimens
The semi-quantitative analysis and NeuN immunohistochemi-
cal staining identiﬁed 3 different types of HS in the postoperative
hippocampal specimens (Fig. 1 and Table 2). HS ILAE type
1 = ‘‘severe neuronal cell loss and gliosis predominantly in CA1
and CA4 regions’’ (neuronal densities = 17.2  0.66 and 15.7  0.99/
mm2, n = 49); HS ILAE type 2 = ‘‘predominant neuronal cell loss and
gliosis in CA1 region’’ (neuronal densities = 17.0  1.59 and
28.6  0.64/mm2, n = 27); HS ILAE type 3 = ‘‘predominant neuronal
cell loss and gliosis in CA4 region’’ (neuronal densities =
29.9  0.66 and 16.1  0.98/mm2, n = 24). In contrast, the patients
in the normal control group showed no neuronal cell loss in CA1 and
CA4 regions (neuronal densities = 30.3  0.96 and 29.4  0.77/mm2,
n = 7).
3.3. Correlation between HS ILAE types and IPI
The correlation between HS ILAE types and IPI in patients with
HS was assessed. The highest incidence of IPI was noted in the HS
ILAE type 1 group (53.1%). Most patients in the HS ILAE type 2 and
type 3 groups did not have a history of IPI (88.9% and 91.7%
respectively). There was the signiﬁcant correlation between HS
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square test) (Table 3).
3.4. Correlation between HS ILAE types and epilepsy duration
We also assessed the correlation between HS ILAE types and
epilepsy duration. Epilepsy duration was deﬁned as the period
from the onset of the ﬁrst seizure to time of operation. The shortest
epilepsy duration was recorded in the HS ILAE type 2 group (mean
epilepsy duration = 6.64  5.83 years). However, the patients in HS
ILAE type 1 or type 3 group showed longer epilepsy duration (mean
epilepsy duration = 15.21  10.33, or 16.92  10.56 years respective-
ly). There was the statistically signiﬁcant correlation between the HS
ILAE types and epilepsy duration among the groups (P < 0.001,
variance analysis with one-way ANOVA) (Table 4).
3.5. Correlation between HS ILAE types and long-term postoperative
seizure outcome
The long-term postoperative seizure outcome in patients with
HS was further assessed according to the ILAE outcome classiﬁca-
tion. Class 1: completely seizure free without auras; class 2: only
auras without other seizures; class 3: one to three seizure days per
year with or without auras; class 4–6: less favorable seizure
outcomes. The postsurgical seizure outcome in patients with HS
was obtained every year during the 7-year postoperative follow-up
(Fig. 2). In the ﬁrst year after surgery, the probability that the
patients remaining in class 1, 2, 3, or 4+ were 61.22%, 18.37%, 10.2%,Table 3
Correlations between HS ILAE types and IPI.
IPI No-IPI Total
N % N %
HS ILAE type 1 26 53.1 23 46.9 49
HS ILAE type 2 3 11.1 24 88.9 27
HS ILAE type 3 2 8.3 22 91.7 24
Total 31 31 69 69 100
HS: hippocampal sclerosis, IPI: initial precipitating injury, ILAE: International
League Against Epilepsy, and N: number of patients.
Table 4
Correlations between HS ILAE types and epilepsy duration.
N Epilepsy duration (years)
Mean SD
HS ILAE type 1 49 15.21 10.33
HS ILAE type 2 27 6.64 5.83
HS ILAE type 3 24 16.92 10.56
HS: hippocampal sclerosis, ILAE: International League Against Epilepsy, N: number
of patients, and SD: standard deviation.
Fig. 2. Seizure outcome (ILAE classiﬁcation) during the 7 year postoperative follow-up. (
patients in the HS ILAE type 2 group; (C) seizure outcome of patients in the HS ILAE tor 10.2% respectively in the HS ILAE type 1 group; the probability
that the patients remained in class 1, 2, 3, or 4+ was 40.74%, 29.63%,
11.11%, or 18.52% respectively in the HS ILAE type 2 group; the
probability that the patients remained in class 1, 2, 3, or 4+ was
45.83%, 33.33%, 8.33%, or 12.5% respectively in the HS ILAE type
3 group. In the ﬁfth year following surgery, the probability that the
patients remained in class 1, 2, 3, or 4+ was 60%, 33.33%, 6.67%, or
0% respectively in the HS ILAE type 1 group; the probability that the
patients remained in class 1, 2, 3, or 4+ was 47.37%, 21.05%, 15.79%,
or 15.79% respectively in the HS ILAE type 2 group; the probability
that the patients remained in class 1, 2, 3, or 4+ was 35.29%, 29.41%,
23.53%, or 11.76% respectively in the HS ILAE type 3 group. In the
seventh year after surgery, the probability that the patients
remained in class 1, 2, 3, or 4+ was 50%, 30%, 20%, or 0% respectively
in the HS ILAE type 1 group; the probability that the patients
remained in class 1, 2, 3, or 4+ was 14.29%, 14.29%, 42.86%, or
28.57% respectively in the HS ILAE type 2 group; the probability
that the patients remained in class 1, 2, 3, or 4+ was 50%, 16.67%,
16.67%, or 16.67% respectively in the HS ILAE type 3 group. The
completely seizure free rate of patients in all groups declined with
an increase in time. There was the statistically signiﬁcant
difference in postoperative seizure outcome among the different
HS ILAE type groups (P < 0.05, Kaplan–Meier curves). The most
favorable long-term seizure outcome was noted in the HS ILAE
type 1 group. The poorer outcome was observed in the HS ILAE type
2 and type 3 groups. There was no signiﬁcant difference in
postoperative seizure outcome between the last two groups
(Fig. 3).
4. Discussion
Our recent study demonstrated that approximately one-third of
patients with intractable epilepsy did not become seizure-free
after tailored resection strategies.4 The predictors of seizure
outcomes, including IPI, seizure type and frequency, epilepsy
duration, MRI and EEG ﬁndings, and age at resection, have been
identiﬁed.7,12,14–21 Our study for the ﬁrst time demonstrated a
signiﬁcant correlation between HS ILAE types and long-term
postoperative seizure outcome in patients with MTLE due to HS. HS
ILAE type 1 was associated with higher rates of postoperative
seizure-free. The identiﬁcation of the clinicopathological correla-
tion will aid in predicting the long-term seizure outcome of
patients with MTLE due to HS.
IPI has been observed in patients with HS.22 A correlation
between HS and IPI has been previously reported23. One study
demonstrated that the severe neuronal loss in CA1 region was
associated with the occurrence of IPI before the age of seven. More
widespread hippocampal damage comprising all hippocampal
subﬁelds was caused by earlier IPI under the age of 3 years.9 HS and
febrile seizures were associated with a mutation of the SCN1A gene
in early childhood.24 Moreover, dentate granule cell proliferationA) Seizure outcome of patients in the HS ILAE type 1 group; (B) seizure outcome of
ype 3 group.
Fig. 3. Survival analyses for the period to the ﬁrst seizure after surgery.
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granule cells have been reported to functionally integrate into the
hippocampal circuitry,26,27 whereas granule cell proliferation was
limited. Such newborn granule cells could not be detected after age
2.25,28 Furthermore, seizure discharges also stimulated neuronal
apoptosis.28,29 Therefore, aberrant connections were established.
Such alterations further promoted epileptogenesis. Our results
further conﬁrmed that HS ILAE type 1 associated with granule cell
pathology was more frequently correlated with IPI (47.2%, 56.0%).
Whether epilepsy duration similarly inﬂuenced HS types
remains a matter of debate. A study showed a correlation between
epilepsy duration and HS,8 while other studies did not.9,30 Our
ﬁndings illustrated that the shortest epilepsy duration was
recorded in the HS ILAE type 2 group, indicating that CA1 was a
vulnerable subﬁeld.
The analysis of long-term outcomes of temporal lobe epilepsy
surgery demonstrated that patients might relapse after many years
of being seizure free. McIntosh et al. showed the probability of
complete seizure freedom at 10 years after surgery was 41%.31
Paglioli et al.2 demonstrated Kaplan–Meier estimates of complete
seizure freedom for years 5 and 10 were 74% and 66% respectively.
In two recent studies, the seizure free rate at 5 years or 10 years
was 55% or 53% respectively.32,33 More recently, Mohammed et al.
performed a long-term longitudinal study on epilepsy outcomes
(mean: 26 years) in patients with a variety of seizure types, and
showed that about 48% of these patients were seizure free.34
Additionally, Hemb et al. illustrated the probability of remaining
completely seizure-free at 12 and 18 years after MTLE/HS surgery
was 65% and 62% respectively.1 However, the precise association
between HS ILAE types and long-term postsurgical seizure
outcome has been never reported. To ensure the reliability of
our study, all MTLE patient data were collected in the same
epilepsy center. More importantly, all the operations were
performed by the same professor, who has nearly had 15 years
of experience in the surgical treatment of epilepsy. In this study,
the follow-up period was 7 years, and the ILAE outcome
classiﬁcation system was employed. The higher rates of long-
term postoperative seizure-free were observed in the HS ILAE type
1 group. A favorable postsurgical outcome has always been
associated with HS severity.7,35–39 Therefore, our results indicated
that HS ILAE types could predict the long-term postoperative
seizure outcome of patients with MTLE due to HS.
There are some limitations in our study. We only assessed the
seizure outcome in patients with MTLE. The postoperative
outcomes in epilepsy patients should also include other important
factors, such as cognition, memory, and psychological condition.Further separate studies would be informative regarding these
postoperative outcomes. Clinical observations are dependent on
the accuracy of the case records, and as in all clinicopathologic
studies there may be inaccuracies regarding recollection of IPI
events and seizure history. In addition, another drawback in this
study is lack of the collaboration between neurosurgeons,
epileptologists, neuropsychologists, and neuroradiologists.
5. Conclusion
In conclusion, our study demonstrated a signiﬁcant association
between IPI and HS ILAE type 1. It suggested that IPI has a
signiﬁcant effect on the pathogenesis of HS. In addition, the most
favorable long-term postsurgical seizure outcome was observed in
the HS ILAE type 1 group, and the shortest epilepsy duration was
recorded in the HS ILAE type 2 group. The identiﬁcation of the
clinicopathological correlation will aid in the more accurate
prediction of the long-term postsurgical seizure outcome of
patients with MTLE due to HS.
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